Oncolytics Biotech (ONCY) to Release Quarterly Earnings on Thursday

Oncolytics Biotech (NASDAQ:ONCY) will be posting its quarterly earnings results after the market closes on Thursday, August 1st. Analysts expect Oncolytics Biotech to post earnings of ($0.08) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Oncolytics Biotech (NASDAQ:ONCY) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.02. On average, analysts expect Oncolytics Biotech to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oncolytics Biotech Stock Performance

NASDAQ ONCY opened at $1.05 on Wednesday. Oncolytics Biotech has a 12 month low of $0.88 and a 12 month high of $2.62. The stock has a 50 day moving average of $1.04 and a 200-day moving average of $1.08. The company has a market cap of $80.70 million, a PE ratio of -3.50 and a beta of 1.91.

Analyst Ratings Changes

ONCY has been the topic of a number of research analyst reports. Raymond James began coverage on Oncolytics Biotech in a research note on Thursday, April 4th. They issued an “outperform” rating and a $3.00 price target on the stock. HC Wainwright reiterated a “buy” rating and set a $5.00 price objective on shares of Oncolytics Biotech in a research report on Tuesday, May 14th.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.